Coronavirus Disease (COVID-19)
Infectious Disease·MeSH: COVID-19
Prevalence
10000.0 / 100K
Incidence
5000.0 / 100K/yr
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(2)
Unknown(1)
| Drug | Company |
|---|---|
| diphenhydramine | Mesoblast Limited (MESO) |
Compare drugs
Frequently asked questions
How many drugs are in development for Coronavirus Disease (COVID-19)?
BioSniper tracks 3 drugs in development for Coronavirus Disease (COVID-19) across 2 companies.
How many clinical trials target Coronavirus Disease (COVID-19)?
There are 1 clinical trial targeting Coronavirus Disease (COVID-19) tracked by BioSniper.
What is the prevalence of Coronavirus Disease (COVID-19)?
The estimated prevalence of Coronavirus Disease (COVID-19) is approximately 10000.0 per 100,000 population.
Deep-dive into Coronavirus Disease (COVID-19)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis